|
ABOUT COMPANY
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and delivering therapies to treat liver and other chronic diseases. The company is headquartered in Newark, California.
|
EARNINGS
Gross Profit (TTM): -22893000
Market Capitalization: 286181000
Operating Margin (TTM): 0
PE Ratio: None
PEG Ratio: 0
Profit Margin: 0
Revenue Per Share (TTM): 0
Revenue (TTM): 0
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -1.148
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -91225000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|